1. Defendant A shall be punished by a fine of seven million won.

Defendant

A fails to pay the above fine.

Punishment of the crime

No medical person, etc. shall receive money, goods, benefits, labor, entertainment, or other economic benefits provided by a person who has obtained permission for items under the Pharmaceutical Affairs Act or a person who has filed a report on items for the purpose of sales promotion, such as inducing the adoption of drugs.

1. Defendant A operated the “L member” located in the Eunpyeong-gu Seoul Metropolitan Government K from December 2, 2010 to July 2012; Defendant A worked as the head of the division within the “N Medical Foundation O hospital of Seodaemun-gu, Seoul from December 2, 2012 to March 2014.

It is the intention.

Defendant

A received a proposal from a business employee P to “to provide economic benefits, such as cash, by prescribing prescription drugs, such as a pentll, which are produced and sold in the soking,” and received the proposal. On December 2010, A received KRW 250,000 from P in cash from the above Lwon's clinic around the same manner, and was issued KRW 1,279,00 in total by March 29, 2014 by the same method as in the list of crimes (Defendant A).

As a result, Defendant A received cash amounting to KRW 1,2790,000 provided for the purpose of sales promotion such as inducing the adoption of medicines.

2. Defendant B is a doctor to operate “R internal council members” in Eunpyeong-gu Seoul Metropolitan Government Q.

Defendant

B Upon receipt of a proposal from P to the effect that “to provide economic benefits, such as cash, by prescribing prescription drugs, such as pentlls, which are produced and sold in malking,” from P, and to comply with it. On December 2010, B received a total of KRW 3,480,000,000 in total from April 28, 2014 by the same method as in the list of crimes in the attached Form (Defendant B) including obtaining a gift certificate equivalent to KRW 50,000 from P from the above member’s clinic around December 2010.

As a result, Defendant B is provided with the aim of promoting sales such as inducing the adoption of medicines from the softing.